Pandion is a biotechnology company that develops and commercializes antibody therapeutics for the treatment of autoimmune and inflammatory diseases... Read more
Pandion is a biotechnology company that develops and commercializes antibody therapeutics for the treatment of autoimmune and inflammatory diseases... Read more
2017
PublicSubsidiary of Merck & Co., Inc.NASDAQPAND
News
Feb 09, 2022
The Business Journals
Pandion Therapeutics: Pandion founder launches new startup tackling autoimmune disease
Feb 08, 2022
FierceBiotechIT
Pandion Therapeutics: Seismic emerges with $101M, Harvard billionaire founder and leadership team fresh off $1.9B exit
Apr 01, 2021
NJBIZ
Pandion Therapeutics: Merck completes acquisition of Pandion Therapeutics
Mar 16, 2021
Contract Pharma
Pandion Therapeutics: Selexis, Pandion Enter Antibody Service Agreement
Mar 10, 2021
News Break
Pandion Therapeutics: Merck Bumps its Offer from Original $65M to $1.85B to Acquire Pandion Therapeutics | News Break
Mar 04, 2021
BioSpace
Pandion Therapeutics: Merck Begins Tender Offer to Acquire Pandion Therapeutics
Feb 27, 2021
Zephyr Net
Pandion Therapeutics: SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Pandion Therapeutics, Inc. - PAND
Feb 27, 2021
Pharmabiz
Pandion Therapeutics: Merck to acquire drug developer Pandion Therapeutics for $ 1.85 billion
Feb 26, 2021
Pharmafile
Pandion Therapeutics: MSD acquires Pandion Therapeutics in $1.85bn deal
Feb 25, 2021
The Pharma Letter
Pandion Therapeutics: Merck getting on Treg train with $1.85B acquisition
Pandion Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10